Edaravone improves the expression of nerve growth factor in human astrocytes subjected to hypoxia/reoxygenation
Authors:
- 31 March 2010
- journal article
- Published by Elsevier in Neuroscience Research
- Vol. 66 (3) , 284-289
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The Levels of Retinoic Acid-Inducible Gene I Are Regulated by Heat Shock Protein 90-αThe Journal of Immunology, 2009
- Edaravone for the treatment of acute cerebral infarction: role of endothelium-derived nitric oxide and oxidative stressExpert Opinion on Pharmacotherapy, 2009
- Antagonistic control of cell fates by JNK and p38-MAPK signalingCell Death & Differentiation, 2007
- JNK and PI3K differentially regulate MMP-2 and MT1-MMP mRNA and protein in response to actin cytoskeleton reorganization in endothelial cellsAmerican Journal of Physiology-Cell Physiology, 2006
- Neuroprotective Effects of Edaravone: a Novel Free Radical Scavenger in Cerebrovascular InjuryCNS Drug Reviews, 2006
- Mitogen-activated protein kinases in apoptosis regulationOncogene, 2004
- ERK, JNK, and p38 MAP kinases differentially regulate proliferation and migration of phenotypically distinct smooth muscle cell subtypesJournal of Cellular Biochemistry, 2003
- p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2–stimulated angiogenesisJournal of Cell Biology, 2002
- Expression of Nerve Growth Factor and trkA After Transient Focal Cerebral Ischemia in RatsStroke, 1998
- Expression of nerve growth factor in brown adipose tissue: implications for thermogenesis and obesityEndocrinology, 1996